Drug recall · October 28, 2026
Amlodipine and Olmesartan Medoxomil Tablets recall
Why: Out of specification due to dissolution.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Amlodipine and Olmesartan Medoxomil Tablets, 10mg/40mg, 30 Tablets, Rx only, Manufactured by: Alkem Laboratories Ltd., INDIA, Distributed by: Ascend Laboratories, LLC, Parsippany, NJ 07054, NDC 67877-502-30.
- Lots / codes
Lot # 25120696, Exp Date: December 31, 2026.
- Quantity
- 11,424 bottles.
- Company
- Ascend Laboratories, LLC, Bedminster, NJ
- Distribution
- Nationwide within the United States
- Initiated
- October 6, 2026 · Voluntary: Firm initiated
- Classified
- October 16, 2026
- Reported
- October 28, 2026
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Amlodipine / olmesartan
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.